Save time and get answers to complex questions with AI chat
Prolia and osteonecrosis?Dabrafenib mesylate when the patent is expiring in india?Defense strategy against generic in niche market?Abbvie humira patent cliff navigation success?Diltiazem drug class?
See the DrugPatentWatch profile for toujeo
Short answer: no, there isn’t a generic version of Toujeo. Details: - Toujeo is insulin glargine U-300 (a concentrated long-acting insulin). - In the U.S., there is no approved generic or biosimilar specifically for Toujeo U-300. - There are biosimilars for insulin glargine U-100 (Lantus), such as Basaglar and Semglee, but they are not interchangeable with Toujeo because of the different concentrations (U-100 vs U-300). Switching would require dose conversion and physician supervision. If cost or access is an issue, talk with your prescriber or pharmacist about: - Switching to a U-100 insulin glargine biosimilar or another long-acting insulin after proper dose adjustment. - Available patient assistance programs or formulary options in your country. If you’d like, tell me your country and I can share more specific options.
Other Questions About Toujeo :